K213517

Substantially Equivalent

Access Thyroglobulin Antibody II

Applicant: Beckman Coulter, Inc.
Product code: JZO
Advisory panel: Immunology
Date received: 2021-11-03
Decision date: 2023-09-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Chaska, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.